GAM Holding AG - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 200 filers reported holding SAGE THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 1.86 and the average weighting 0.3%.

Quarter-by-quarter ownership
GAM Holding AG ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$749,000
-40.0%
13,179
-21.0%
0.03%
-44.8%
Q1 2021$1,248,000
-32.0%
16,672
-44.4%
0.06%
-47.3%
Q3 2020$1,834,000
+47.1%
30,0000.0%0.11%
+41.0%
Q2 2020$1,247,000
+44.7%
30,0000.0%0.08%
+32.2%
Q1 2020$862,000
-52.6%
30,000
+19.0%
0.06%
-31.4%
Q4 2019$1,819,000
+7.1%
25,200
+108.3%
0.09%
+14.7%
Q3 2019$1,698,000
-47.0%
12,100
-30.9%
0.08%
-40.0%
Q2 2019$3,204,000
+3.3%
17,500
-10.3%
0.12%
-3.8%
Q1 2019$3,101,000
-2.8%
19,500
-41.4%
0.13%
-19.3%
Q4 2018$3,190,000
+43.8%
33,300
+112.1%
0.16%
+98.8%
Q3 2018$2,218,000
-9.8%
15,7000.0%0.08%
-4.7%
Q2 2018$2,458,000
-2.8%
15,7000.0%0.08%
-4.5%
Q1 2018$2,529,000
-72.2%
15,700
-71.6%
0.09%
-68.1%
Q4 2017$9,108,000
+85.3%
55,300
-29.9%
0.28%
+34.8%
Q3 2017$4,915,000
-21.8%
78,9000.0%0.21%
+122.6%
Q2 2017$6,284,000
-4.2%
78,900
-14.5%
0.09%
-10.6%
Q1 2017$6,560,000
+39.2%
92,3000.0%0.10%
+25.3%
Q4 2016$4,713,000
+28.9%
92,300
+16.2%
0.08%
+29.7%
Q3 2016$3,656,000
-23.6%
79,400
-50.0%
0.06%
-13.5%
Q2 2016$4,785,000
+87.9%
158,800
+100.0%
0.07%
+76.2%
Q1 2016$2,546,000
-45.0%
79,4000.0%0.04%
-41.7%
Q4 2015$4,629,000
+139.8%
79,400
+74.1%
0.07%
+118.2%
Q3 2015$1,930,000
+166.9%
45,600
+360.6%
0.03%
+230.0%
Q2 2015$723,0009,9000.01%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Finepoint Capital LP 475,600$15,362,0005.31%
Integral Health Asset Management, LLC 412,257$13,316,0002.74%
Palo Alto Investors LP 851,409$27,501,0002.40%
Boxer Capital, LLC 1,094,000$35,336,0002.24%
DAFNA Capital Management LLC 180,306$5,824,0001.59%
Ikarian Capital, LLC 250,000$8,075,0001.47%
Bellevue Group AG 2,973,178$96,034,0001.36%
SECTOR GAMMA AS 118,476$3,827,0000.86%
Artal Group S.A. 450,000$14,535,0000.78%
Diametric Capital, LP 19,393$626,0000.46%
View complete list of SAGE THERAPEUTICS INC shareholders